265 related articles for article (PubMed ID: 30284985)
1. Notch signaling suppresses glucose metabolism in mesenchymal progenitors to restrict osteoblast differentiation.
Lee SY; Long F
J Clin Invest; 2018 Dec; 128(12):5573-5586. PubMed ID: 30284985
[TBL] [Abstract][Full Text] [Related]
2. Sustained Notch2 signaling in osteoblasts, but not in osteoclasts, is linked to osteopenia in a mouse model of Hajdu-Cheney syndrome.
Zanotti S; Yu J; Sanjay A; Schilling L; Schoenherr C; Economides AN; Canalis E
J Biol Chem; 2017 Jul; 292(29):12232-12244. PubMed ID: 28592489
[TBL] [Abstract][Full Text] [Related]
3. Hajdu Cheney Mouse Mutants Exhibit Osteopenia, Increased Osteoclastogenesis, and Bone Resorption.
Canalis E; Schilling L; Yee SP; Lee SK; Zanotti S
J Biol Chem; 2016 Jan; 291(4):1538-1551. PubMed ID: 26627824
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotides targeting
Canalis E; Grossman TR; Carrer M; Schilling L; Yu J
J Biol Chem; 2020 Mar; 295(12):3952-3964. PubMed ID: 31992595
[TBL] [Abstract][Full Text] [Related]
5. High Bone Turnover in Mice Carrying a Pathogenic Notch2 Mutation Causing Hajdu-Cheney Syndrome.
Vollersen N; Hermans-Borgmeyer I; Cornils K; Fehse B; Rolvien T; Triviai I; Jeschke A; Oheim R; Amling M; Schinke T; Yorgan TA
J Bone Miner Res; 2018 Jan; 33(1):70-83. PubMed ID: 28856714
[TBL] [Abstract][Full Text] [Related]
6. Hyperglycemia inhibits osteoblastogenesis of rat bone marrow stromal cells via activation of the Notch2 signaling pathway.
Huang KC; Chuang PY; Yang TY; Huang TW; Chang SF
Int J Med Sci; 2019; 16(5):696-703. PubMed ID: 31217737
[No Abstract] [Full Text] [Related]
7. Osteoblast-specific Notch2 inactivation causes increased trabecular bone mass at specific sites of the appendicular skeleton.
Yorgan T; Vollersen N; Riedel C; Jeschke A; Peters S; Busse B; Amling M; Schinke T
Bone; 2016 Jun; 87():136-46. PubMed ID: 27102824
[TBL] [Abstract][Full Text] [Related]
8. Physiological notch signaling maintains bone homeostasis via RBPjk and Hey upstream of NFATc1.
Tu X; Chen J; Lim J; Karner CM; Lee SY; Heisig J; Wiese C; Surendran K; Kopan R; Gessler M; Long F
PLoS Genet; 2012; 8(3):e1002577. PubMed ID: 22457635
[TBL] [Abstract][Full Text] [Related]
9. Mice harboring a Hajdu Cheney Syndrome mutation are sensitized to osteoarthritis.
Zanotti S; Yu J; Bridgewater D; Wolf JM; Canalis E
Bone; 2018 Sep; 114():198-205. PubMed ID: 29940267
[TBL] [Abstract][Full Text] [Related]
10. Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss.
Simpson MA; Irving MD; Asilmaz E; Gray MJ; Dafou D; Elmslie FV; Mansour S; Holder SE; Brain CE; Burton BK; Kim KH; Pauli RM; Aftimos S; Stewart H; Kim CA; Holder-Espinasse M; Robertson SP; Drake WM; Trembath RC
Nat Genet; 2011 Mar; 43(4):303-5. PubMed ID: 21378985
[TBL] [Abstract][Full Text] [Related]
11. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation.
Hilton MJ; Tu X; Wu X; Bai S; Zhao H; Kobayashi T; Kronenberg HM; Teitelbaum SL; Ross FP; Kopan R; Long F
Nat Med; 2008 Mar; 14(3):306-14. PubMed ID: 18297083
[TBL] [Abstract][Full Text] [Related]
12. Hairy and enhancer of split 1 is a primary effector of NOTCH2 signaling and induces osteoclast differentiation and function.
Yu J; Schilling L; Eller T; Canalis E
J Biol Chem; 2021 Dec; 297(6):101376. PubMed ID: 34742737
[TBL] [Abstract][Full Text] [Related]
13. Maintenance of Bone Homeostasis by DLL1-Mediated Notch Signaling.
Muguruma Y; Hozumi K; Warita H; Yahata T; Uno T; Ito M; Ando K
J Cell Physiol; 2017 Sep; 232(9):2569-2580. PubMed ID: 27735989
[TBL] [Abstract][Full Text] [Related]
14. miRNA-34c regulates Notch signaling during bone development.
Bae Y; Yang T; Zeng HC; Campeau PM; Chen Y; Bertin T; Dawson BC; Munivez E; Tao J; Lee BH
Hum Mol Genet; 2012 Jul; 21(13):2991-3000. PubMed ID: 22498974
[TBL] [Abstract][Full Text] [Related]
15. Jagged1 expression by osteoblast-lineage cells regulates trabecular bone mass and periosteal expansion in mice.
Youngstrom DW; Dishowitz MI; Bales CB; Carr E; Mutyaba PL; Kozloff KM; Shitaye H; Hankenson KD; Loomes KM
Bone; 2016 Oct; 91():64-74. PubMed ID: 27416809
[TBL] [Abstract][Full Text] [Related]
16. Clinical and experimental aspects of notch receptor signaling: Hajdu-Cheney syndrome and related disorders.
Canalis E
Metabolism; 2018 Mar; 80():48-56. PubMed ID: 28941602
[TBL] [Abstract][Full Text] [Related]
17. The Hajdu Cheney mutation sensitizes mice to the osteolytic actions of tumor necrosis factor α.
Yu J; Canalis E
J Biol Chem; 2019 Sep; 294(39):14203-14214. PubMed ID: 31371452
[TBL] [Abstract][Full Text] [Related]
18. NOTCH2 Hajdu-Cheney Mutations Escape SCF
Fukushima H; Shimizu K; Watahiki A; Hoshikawa S; Kosho T; Oba D; Sakano S; Arakaki M; Yamada A; Nagashima K; Okabe K; Fukumoto S; Jimi E; Bigas A; Nakayama KI; Nakayama K; Aoki Y; Wei W; Inuzuka H
Mol Cell; 2017 Nov; 68(4):645-658.e5. PubMed ID: 29149593
[TBL] [Abstract][Full Text] [Related]
19. Hajdu-Cheney syndrome: a review.
Canalis E; Zanotti S
Orphanet J Rare Dis; 2014 Dec; 9():200. PubMed ID: 25491639
[TBL] [Abstract][Full Text] [Related]
20. Fracture healing in a mouse model of Hajdu-Cheney-Syndrome with high turnover osteopenia results in decreased biomechanical stability.
Ballhause TM; Jiang S; Xie W; Sevecke J; Dowling C; Dust T; Brandt S; Mertens PR; Yorgan TA; Schinke T; Frosch KH; Baranowsky A; Keller J
Sci Rep; 2023 Jul; 13(1):11418. PubMed ID: 37452111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
